Clinical Research

New gene therapy may help protect the hearts of patients with Friedreich's ataxia
A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.
Long-term cardiac amyloidosis survival benefits seen in extension acoramidis trial
Patient outcomes clearly show acoramidis reduces both all-cause mortality and cardiovascular hospitalizations, but the study also reinforced the importance of early diagnosis and prompt medical therapy.
FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system
The TRiCares Topaz uses a unique two-stent frame valve prosthesis for better sealing and flexibility.
Deepak Bhatt discusses some of the most impactful trials at ACC 2026
Bhatt describes a mix of drug, device and strategy trials pointing to advances in cardiovascular science.
Screening and treatment for chronic kidney disease in heart disease patients needs to be expanded
The risk associated with under-recognized CKD emerged early, highlighting the need for screening soon after a CAD diagnosis so that cardio-renal protective drugs can be started much earlier.

Researchers simulate red blood cells, oxygen flow using low-frequency ultrasound

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Isotope used in cancer drug development shipped for clinical trials

Actinium-225 remains in short supply, slowing drug research.

Premature births can be predicted at 23 weeks using ultrasound

The method was developed based on 22 years of research and has been shown effective in a new study.

UVA Health receives $3.1M grant for using ultrasound to deliver drugs into the brain

Researchers are aiming to use ultrasound to breach the blood-brain barrier and deliver drug therapies.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Pre-clinical images of the Abbott Volt pulsed field ablation system creating lesions using electroporation, presented at the 2023 AHA Scientific Sessions, The Abbott PFA system is now being used in a first-in-human study at the Centre for Heart Rhythm Disorders at the University of Adelaide, Australia.

First patients treated with Abbott’s pulsed field ablation offering

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.

Vanderbilt University Medical Center sign

Vanderbilt scores $3.2M NIH grant to analyze MRI's role in improving epilepsy surgery

The five-year grant builds upon a growing body of research to better identify patients who would benefit from surgical interventions.

weight loss scale overweight obese lose weight pounds

TAVR in patients with severe obesity: Longer hospital stays, higher costs, more health risks

The CDC defines severe obesity, or class III obesity, as any patient with a BMI of 40 or higher. TAVR among these patients is not associated with a lower survival rate, but it does lead to many more risks.

Clinical Research

New gene therapy may help protect the hearts of patients with Friedreich's ataxia

Long-term cardiac amyloidosis survival benefits seen in extension acoramidis trial

FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system

Deepak Bhatt discusses some of the most impactful trials at ACC 2026

Screening and treatment for chronic kidney disease in heart disease patients needs to be expanded